Literature DB >> 175919

Biology of feline leukemia virus in the natural environment.

W D Hardy, P W Hess, E G MacEwen, A J McClelland, E E Zuckerman, M Essex, S M Cotter, O Jarrett.   

Abstract

The feline leukemia virus (FeLV) was discovered in 1964 in a cluster of cats with lymphosarcoma. The observed clustering of cases of feline lymphosarcoma suggested that FeLV was an infectious agent for cats. The development of a simple immunofluorescent test for FeLV permitted a seroepidemiological study to be undertaken on the distribution of the virus in cats living in their natural environment. Over 2000 cats were tested, and the results showed conclusively that FeLV is an infectious agent for cats. This finding has now been independently confirmed using three different test procedures. After the infectious nature of FeLV was discovered, a simple FeLV test and removal program was devised to control the spread of the virus in the natural environment. The spread of FeLV was controlled in 45 households by removing the FeLV-infected cats, while in 25 households, where the infected cats were left in contact with the uninfected cats, 12% of the uninfected cats became infected. The ultimate control of FeLV awaits the development of an effective FeLV vaccine, which now seems feasible since we have already experimentally immunized some cats with attenuated FeLV. Although FeLV is infectious for cats there is no evidence that FeLV can infect humans.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 175919

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  47 in total

1.  Host range and receptor binding properties of vectors bearing feline leukemia virus subgroup B envelopes can be modulated by envelope sequences outside of the receptor binding domain.

Authors:  Peggy Ho Faix; Steven A Feldman; Julie Overbaugh; Maribeth V Eiden
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 2.  Feline leukemia virus: current status of the feline induced immune depression and immunoprevention.

Authors:  R G Olsen; M G Lewis; L J Lafrado; L E Mathes; K Haffer; R Sharpee
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Effects of cobra venom factor treatment on latent feline leukemia virus infection.

Authors:  E H Kraut; J L Rojko; R G Olsen; D L Tuomari
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

4.  Feline Pit2 functions as a receptor for subgroup B feline leukemia viruses.

Authors:  M M Anderson; A S Lauring; S Robertson; C Dirks; J Overbaugh
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Feline leukemia virus immunity induced by whole inactivated virus vaccination.

Authors:  Andrea N Torres; Kevin P O'Halloran; Laurie J Larson; Ronald D Schultz; Edward A Hoover
Journal:  Vet Immunol Immunopathol       Date:  2009-10-31       Impact factor: 2.046

Review 6.  Endogenous env elements: partners in generation of pathogenic feline leukemia viruses.

Authors:  P Roy-Burman
Journal:  Virus Genes       Date:  1995       Impact factor: 2.332

7.  Pre- and postexposure chemoprophylaxis: evidence that 3'-azido-3'-dideoxythymidine inhibits feline leukemia virus disease by a drug-induced vaccine response.

Authors:  L E Mathes; P J Polas; K A Hayes; C L Swenson; S Johnson; G J Kociba
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

8.  Comparative analysis of the genomes of feline leukemia viruses.

Authors:  Z F Rosenberg; F S Pedersen; W A Haseltine
Journal:  J Virol       Date:  1980-08       Impact factor: 5.103

9.  Endogenous RD-114 virus genome expression in malignant tissues of domestic cats.

Authors:  H L Niman; M B Gardner; J R Stephenson; P Roy-Burman
Journal:  J Virol       Date:  1977-09       Impact factor: 5.103

10.  Exposure of cats to low doses of FeLV: seroconversion as the sole parameter of infection.

Authors:  Andrea Major; Valentino Cattori; Eva Boenzli; Barbara Riond; Peter Ossent; Marina Luisa Meli; Regina Hofmann-Lehmann; Hans Lutz
Journal:  Vet Res       Date:  2009-10-28       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.